Trials / Conditions / Neurofibromatosis Type II
Neurofibromatosis Type II
3 registered clinical trials studyying Neurofibromatosis Type II — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Study to Determine Optimal Dose, Evaluate the Efficacy and Safety of PRG-N-01 in Patients With Neurofibromatos NCT07131722 | PRG Science & Technology Co., Ltd. | Phase 1 / Phase 2 |
| Recruiting | Familial Investigations of Childhood Cancer Predisposition NCT03050268 | St. Jude Children's Research Hospital | — |
| Completed | Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2 NCT01419639 | NYU Langone Health | Phase 2 |